Alerts will be sent to your verified email
Verify EmailHALEOSLABS
|
Haleos Labs
|
Nectar Lifesciences
|
Everest Organics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.86 % | 0.55 % | 6.44 % |
|
5yr average Equity Multiplier
|
2.28 | 2.12 | 3.85 |
|
5yr Average Asset Turnover Ratio
|
0.85 | 0.73 | 0.99 |
|
5yr Avg Net Profit Margin
|
4.95 % | -2.27 % | 1.46 % |
|
Price to Book
|
1.89 | 0.35 | 3.38 |
|
P/E
|
19.72 | 0.0 | 42.05 |
|
5yr Avg Cash Conversion Cycle
|
-6.07 Days | 88.68 Days | -104.59 Days |
|
Inventory Days
|
78.84 Days | 136.85 Days | 70.24 Days |
|
Days Receivable
|
56.81 Days | 69.3 Days | 188.66 Days |
|
Days Payable
|
142.69 Days | 116.07 Days | 263.18 Days |
|
5yr Average Interest Coverage Ratio
|
4.18 | 0.46 | 2.08 |
|
5yr Avg ROCE
|
11.01 % | 3.29 % | 11.9 % |
|
5yr Avg Operating Profit Margin
|
10.73 % | 5.36 % | 5.27 % |
|
5 yr average Debt to Equity
|
0.52 | 0.71 | 0.88 |
|
5yr CAGR Net Profit
|
8.2 % | 9.19 % | n/a |
|
5yr Average Return on Assets
|
4.32 % | -1.73 % | 2.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.11 % | 51.84 % | 59.58 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | -3.96 % | -14.57 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Haleos Labs
|
Nectar Lifesciences
|
Everest Organics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
API Break-Up
|
API Break-Up
|
-
|
-
|